Medidata Ai Trial Design Solutions offers new ways of generating evidence by allowing clinical development teams to combine real world data and the most robust source of cross-industry, patient-level historical clinical trial data - including 30,000 trials and 9 million patients from over 150 countries and complete with the endpoints and covariates as they were validated as a part of the initial studies. Trial Design develops powerful insights and increases your trials probability of technical and regulatory success by helping to inform protocol design and predict trial obstacles, including:
- Providing scenario-based modeling to define inclusion/exclusion criteria
- Design adaptive trials and inform dosing strategies
- Understanding the likelihood of adverse events within patient sub-populations
- Demonstrating unmet medical need under the current standard of care to show therapeutic efficacy or provide a case for label expansion
Trial Design develops powerful insights, makes evidence-based decisions, and increases the probability of technical and regulatory success in clinical trials. Trial Design has the ability to create powerful modeling for your trial by connecting the data from 30,000 cross-sponsor historical trials with more than 9 million patients from over 150 countries.